BREAKING NEWS: Oval Office Event Abruptly Ends When Man In Attendance Suffers Medical Emergency

We estimate by tens of billions of dollars a year and most importantly, higher productivity. Today is about freeing Americans from the weight, literally and figuratively, that holds us back. It's about unlocking the potential of every citizen to live fully, to contribute fully, and to find joy in their health. We cannot reach our full potential as a nation if we do not reach our full potential as individuals. And we cannot reach our full potential as individuals if we are not healthy. Thanks to Nova and Lily for showing up so constructively over the last several months

to make this possible. In particular, thanks to you, Mr. President, for again demonstrating that you fight for every American, this time for potential. It's now my sincere pleasure to first introduce Dave Ricks from Lilly and then Mike Duestar from Novo.

The Vice President's Secretary, Mike Duestar

Great. Thank you, Chris. It's truly an honor to be here today for this historic step forward to expand access to a class of medications that can fundamentally change the arc of chronic disease in our country.

Of course, these are the Incretin or GLP-1 agonists that we've been speaking about. For nearly 150 years, my company, Eli Lilly, has been investing in America. We've been advancing science and creating high value jobs. But today we, oh, are you okay?

Gordon, you okay?

Yeah.

Press, press, press, we're going.

Thank you, press.

Press, press, press, press.

Cameras, we're done with the cameras. Cameras, we're done with the cameras. Photographers, move.